07:00 , Mar 18, 2013 |  BC Week In Review  |  Company News

Dainippon Sumitomo, Nippon Shinyaku deal

Dainippon granted Nippon exclusive rights to develop and commercialize SMP-986 in Japan for urological diseases. Dainippon will receive an undisclosed upfront payment and is eligible for milestones and royalties. The dual muscarinic receptor...